DIN 02563266 — CISATRACURIUM BESYLATE INJECTION USP MULTI-DOSE 2 MG
CISATRACURIUM BESYLATE INJECTION USP MULTI-DOSE is a solution of Cisatracurium marketed by STERIMAX INC. The full Cisatracurium monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02563266
- Brand name
- CISATRACURIUM BESYLATE INJECTION USP MULTI-DOSE
- Active ingredient
- Cisatracurium
- Strength
- 2 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- STERIMAX INC
- Health Canada status
- MARKETED
- Drug class
- Non-depolarizing neuromuscular blocking agent (skeletal muscle relaxant)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Cisatracurium products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02408813 | CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE | 2 MG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED |
| 02408805 | CISATRACURIUM OMEGA SINGLE DOSE | 2 MG | SOLUTION | OMEGA LABORATORIES LIMITED | DORMANT |